Researchers Test Drug Transfer Using Placenta-On-A-Chip

News   Feb 19, 2018 | Original story from University of Pennsylvania

 
Researchers Test Drug Transfer Using Placenta-On-A-Chip

The Huh lab's placenta-on-a-chip features two microfluidic channels that represent the maternal and fetal circulatory systems, and a membrane with living cells from the placental barrier that separates the two. There are few good options for testing how pharmaceuticals and other supplements might cross the placental barrier during pregnancy. Simulating that barrier on a chip, using human cells, is an alternative to inconclusive animal models, or using placental tissue donated after birth, which have a limited lifespan and require complicated experimental set-ups. Credit: University of Pennsylvania

 
 
 

RELATED ARTICLES

Researchers Awarded $28M for Illuminating Druggable Genome NIH Grants

News

Researchers receive grants as part of the NIH program focused on experimental and informatics approaches to characterize understudied proteins from three gene families: ion channels, G protein-coupled receptors (GPCRs), and protein kinases.

READ MORE

PhoreMost Completes $15M (£11M) Series-A Round to Enter Drug Discovery

News

Investment to fund expansion of operations and progression of drug target pipeline.

READ MORE

Targeting a Leaky Protein that Causes Paralysis

News

A rare genetic disorder in which people are overcome suddenly with profound muscle weakness is caused by a hole in a membrane protein that allows sodium ions to leak across cell membranes. Compounds containing a chemical group called guanidinium can block the pore created by the mutation and stop the sodium leak without altering the voltage sensor’s ability to function.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE